This report models the impact of an improved screening rate for cervical cancer. It finds that the NHS currently spends around £21 million a year treating cervical cancer, while the state loses £9 million in tax revenue from women and their partners who stop work as a result. It argues that if screening coverage were to reach 100%, it estimates that costs to the NHS would almost half, costs to the state would fall by a third, and total costs to women diagnosed with cervical cancer would fall by around 40%. More importantly, incidence of cancer would also almost halve. Based on these findings, the report concludes by offering a set of recommendations for a renewed and concerted effort to increase the number of women regularly attending screening by removing some of the practical, psychological and emotional barriers.